Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin

International Archives of Allergy and Immunology

Volumn 147, Issue 1, 2008, Pages 17-24

  Gambichler, Thilo ^a   Skrygan, Marina ^a   Tomi, Nordwig S ^a   Othlinghaus, Nick ^a   Brockmeyer, Norbert H ^a   Altmeyer, Peter ^a   Kreuter, Alexander ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Antimicrobial peptides; Atopic dermatitis; Human defensin; LL 37; Psoriasin; Psoriasis vulgaris; RNase 7

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN BIOPSY; SKIN INFECTION; STATISTICAL SIGNIFICANCE;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; PSORIASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN;

EID: 49749104216     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128582     Document Type: Article

References (22)

1. Izadpanath A, Gallo RL: Antimicrobial peptides. J Am Acad Dermatol 2005;52:381-390.
2. Schroder JM, Harder J: Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006;63:469-486.
3. Abramovits W: Atopic dermatitis. J Am Acad Dermatol. 2005;53(suppl 1):86-93.
4. Krueger JG, Bowcock A: Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005;64(suppl 2):30-36.
5. Biedermann T: Dissecting the role of infections in atopic dermatitis. Acta Derm Venereol 2006;86:99-109.
6. Henseler T, Christophers E: Disease concomitance in psoriasis. J Am Acad Dermatol 1995;32:982-986.
7. Harder J, Schroder JM: Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 2005;77:476-486.
8. Ong PY, Ohtake T, Brandt C, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
9. Nomura I, Goleva E, Howell MD, et al: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262-3269.
10. Kim JE, Kim BJ, Jeong MS, et al: Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. J Korean Med Sci 2005;20:649-654.
11. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM: Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005;6:57-64.
12. Harder J, Schroder JM: RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002;277:46779-46784.
13. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92(suppl):44-47.
14. Berth-Jones J: Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996;135:25-30.
15. Giulietti A, Overbergh L, Valckx D, Decallone B, Bouillon R, Mathieu C: An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001;25:386-401.
16. -ΔΔCT method. Methods 2001;25:402-408.
17. Howell MD, Novak N, Bieber T, et al: Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 2005;125:738-745.
18. de Jongh GJ, Zeeuwen PLJM, Kucharekova M, et al: High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005;125:1163-1173.
19. Gambichler T, Skrygan M, Tomi NS, Altmeyer P, Kreuter A: Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy. Br J Dermatol 2006;155:1275-1278.
20. Huh WK, Oono T, Shirafuji Y, et al: Dynamic alteration of human β-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin. J Mol Med 2002;80:678-684.
21. Hoover DM, Chertov O, Lubkowski J: The structure of human β-defensin-1: new insights into structural properties of β-defensins. J Biol Chem 2001;276:39021-39026.
22. Howell MD, Boguniewicz M, Pastore S, et al: Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 2006;121:332-338.